Search results
16 sie 2023 · current state of psychedelic drug commercialization, exploring challenges to commercial viability, highlighting ethical considerations, and incorporating lessons from the analogous ketamine and...
17 mar 2022 · Psychedelic drugs such as psilocybin and lysergic acid diethylamide (LSD) have emerging therapeutic potential for neuropsychiatric diseases such as depression and anxiety.
24 paź 2022 · Psychedelics are serotonin 2A receptor agonists that can lead to profound changes in perception, cognition and mood. In this review, we focus on the basic neurobiology underlying the action of...
Psychedelic drugs, acting on the central nervous system, necessitate scrutiny for abuse potential. In the case of Schedule I controlled substances, compliance with DEA regulations is mandatory for activities under an IND.
14 wrz 2020 · Current behavioural and neuroimaging data show that psychedelics induce their psychological effects (Box 1) primarily via 5-hydroxytryptamine (serotonin) type 2A (5-HT 2A) receptor activation...
17 cze 2024 · Enrolling people who use psychedelics through state and nationally regulated pathways in confidential, secure data collection systems could explicitly define the exposed population, capture accurate health outcome measures and demonstrate the safety of state-run programs.
17 maj 2017 · Used most notably as aids to psychotherapy for the treatment of mood disorders and alcohol dependence, drugs such as LSD showed initial therapeutic promise before prohibitive legislature in the mid-1960s effectively ended all major psychedelic research programs.
